Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors

Details for Australian Patent Application No. 2002352090 (hide)

International Classifications

Event Publications

20 March 2003 Complete Application Filed

Priority application(s): 02075052.7 02.01.02 EP

4 September 2003 Application Open to Public Inspection

Published as AU-B-2002352090

22 June 2006 Assignment before Grant

Pharmacia Italia S.p.A. The application has been assigned to Nerviano Medical Sciences S.r.l.

15 May 2008 Application Accepted

Published as AU-B-2002352090

19 June 2008 Corrigenda

Applications Accepted - Name Index Under the Name Nerviano Medical Sciences S.r.l., Application No. 2002352090, under the INID (72), correct the name of the co-inventor to Fowst, Camilla

11 September 2008 Standard Patent Sealed

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.